Il y a eu 50 transactions d'initiés récentes enregistrées pour Catalyst Pharmaceuticals, Inc. (CPRX), dont 19 achats et 29 ventes. Le total des achats d'initiés s'élève à $21.97M et le total des ventes d'initiés à $15.41M.
Les initiés notables ayant une activité récente comprennent Russo Gregg, Daly Richard J, Kalb Michael Wayne. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — CPRX
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-02-17 |
Russo Gregg |
Chief HR Officer |
Retenue Fiscale RSU |
211 |
- |
- |
476 |
| 2026-01-05 |
Daly Richard J |
President and CEO |
Retenue Fiscale RSU |
10,577 |
- |
- |
271,266 |
| 2026-01-05 |
Kalb Michael Wayne |
Executive Vice President & CFO |
Retenue Fiscale RSU |
2,080 |
- |
- |
13,665 |
| 2025-12-29 |
Mcenany Patrick J |
Other: Chairman of Board of Directors |
Exercice d'Options (Vente) |
26,334 |
- |
- |
1,851,948 |
| 2025-12-29 |
Denkhaus Donald A |
Director |
Exercice d'Options (Vente) |
1,334 |
- |
- |
178,163 |
| 2025-12-29 |
Tierney David S |
Director |
Exercice d'Options (Vente) |
1,334 |
- |
- |
178,163 |
| 2025-12-29 |
Miller Steve |
Chief Op. & Scientific Officer |
Exercice d'Options |
14,000 |
- |
- |
1,093,803 |
| 2025-12-29 |
Daly Richard J |
President and CEO |
Retenue Fiscale RSU |
524 |
- |
- |
239,738 |
| 2025-12-29 |
Elsbernd Brian |
Chief Compliance/legal Officer |
Retenue Fiscale RSU |
2,623 |
- |
- |
242,501 |
| 2025-12-29 |
Del Carmen Jeffrey |
Chief Commercial Officer |
Retenue Fiscale RSU |
3,839 |
- |
- |
14,337 |
| 2025-12-29 |
Harper Molly |
Director |
Exercice d'Options |
1,334 |
- |
- |
3,694 |
| 2025-12-29 |
Sundaram Preethi |
Chief Strategy Officer |
Retenue Fiscale RSU |
2,369 |
- |
- |
54,804 |
| 2025-12-12 |
Harper Molly |
Director |
Vente Informative |
6,746 |
$23.06 |
$155.56K |
2,360 |
| 2025-12-08 |
Mcenany Patrick J |
Other: Chairman of Board of Directors |
Exercice d'Options (Vente) |
3,534 |
- |
- |
1,878,282 |
| 2025-12-08 |
Denkhaus Donald A |
Director |
Exercice d'Options (Vente) |
1,413 |
- |
- |
179,497 |
| 2025-12-08 |
Tierney David S |
Director |
Exercice d'Options (Vente) |
1,413 |
- |
- |
179,497 |
| 2025-12-08 |
Miller Steve |
Chief Op. & Scientific Officer |
Exercice d'Options |
11,873 |
- |
- |
1,079,803 |
| 2025-12-08 |
Elsbernd Brian |
Chief Compliance/legal Officer |
Retenue Fiscale RSU |
2,780 |
- |
- |
238,457 |
| 2025-12-08 |
Del Carmen Jeffrey |
Chief Commercial Officer |
Retenue Fiscale RSU |
2,492 |
- |
- |
9,509 |
| 2025-12-08 |
Thompson Tamar |
Director |
Exercice d'Options |
1,413 |
- |
- |
3,773 |
| 2025-12-08 |
Harper Molly |
Director |
Exercice d'Options |
1,413 |
- |
- |
9,106 |
| 2025-12-08 |
Sundaram Preethi |
Chief Strategy Officer |
Retenue Fiscale RSU |
1,669 |
- |
- |
50,506 |
| 2025-12-01 |
Mcenany Patrick J |
Other: Chairman of Board of Directors |
Don (Donné) |
45,000 |
- |
- |
4,148,477 |
| 2025-11-26 |
Del Carmen Jeffrey |
Chief Commercial Officer |
Vente Informative |
10,983 |
$23.33 |
$256.24K |
3,962 |
| 2025-11-21 |
Mcenany Patrick J |
Other: Chairman of Board of Directors |
Exercice d'Options (Vente) |
1,775 |
- |
- |
1,881,816 |
| 2025-11-21 |
Tierney David S |
Director |
Exercice d'Options (Vente) |
947 |
- |
- |
180,910 |
| 2025-11-21 |
Miller Steve |
Chief Op. & Scientific Officer |
Exercice d'Options |
8,267 |
- |
- |
1,067,930 |
| 2025-11-21 |
Daly Richard J |
President and CEO |
Exercice d'Options |
20,006 |
- |
- |
246,800 |
| 2025-11-21 |
Kalb Michael Wayne |
Executive Vice President & CFO |
Retenue Fiscale RSU |
2,485 |
- |
- |
8,606 |
| 2025-11-21 |
Thompson Tamar |
Director |
Exercice d'Options |
947 |
- |
- |
2,360 |
| 2025-11-21 |
Harper Molly |
Director |
Exercice d'Options |
947 |
- |
- |
7,693 |
| 2025-11-21 |
Sundaram Preethi |
Chief Strategy Officer |
Retenue Fiscale RSU |
1,364 |
- |
- |
45,320 |
| 2025-11-20 |
Mcenany Patrick J |
Other: Chairman of Board of Directors |
Attribution de RSU |
34,921 |
$22.77 |
$795.15K |
1,873,051 |
| 2025-11-20 |
Tierney David S |
Director |
Attribution de RSU |
18,115 |
$22.77 |
$412.48K |
176,389 |
| 2025-11-20 |
Miller Steve |
Chief Op. & Scientific Officer |
Attribution de RSU |
158,454 |
$22.77 |
$3.61M |
1,457,963 |
| 2025-11-20 |
Daly Richard J |
President and CEO |
Attribution de RSU |
381,948 |
$22.77 |
$8.7M |
2,546,695 |
| 2025-11-20 |
Kalb Michael Wayne |
Executive Vice President & CFO |
Attribution de RSU |
131,536 |
$22.77 |
$3M |
607,235 |
| 2025-11-20 |
Thompson Tamar |
Director |
Attribution de RSU |
18,115 |
$22.77 |
$412.48K |
116,555 |
| 2025-11-20 |
Harper Molly |
Director |
Attribution de RSU |
18,115 |
$22.77 |
$412.48K |
145,389 |
| 2025-11-20 |
Sundaram Preethi |
Chief Strategy Officer |
Attribution de RSU |
106,873 |
$22.77 |
$2.43M |
785,305 |
| 2025-11-20 |
Russo Gregg |
Chief HR Officer |
Attribution de RSU |
20,531 |
$22.77 |
$467.49K |
66,276 |
| 2025-06-11 |
Sundaram Preethi |
Chief Strategy Officer |
Vente Informative |
1,600 |
$26.42 |
$42.27K |
41,081 |
| 2025-06-10 |
Sundaram Preethi |
Chief Strategy Officer |
Vente Informative |
2,324 |
$26.41 |
$61.38K |
42,681 |
| 2025-06-09 |
Mcenany Patrick J |
Other: Chairman of Board of Directors |
Vente Informative |
171,748 |
$26.11 |
$4.48M |
4,281,702 |
| 2025-06-06 |
Mcenany Patrick J |
Other: Chairman of Board of Directors |
Vente Informative |
28,252 |
$25.95 |
$733K |
4,453,450 |
| 2025-06-02 |
Andrews William T. |
Chief Medical Officer |
Inconnu |
15,261 |
- |
- |
- |
| 2025-05-30 |
Daly Richard J |
President and CEO |
Achat Informatif |
70,000 |
$24.86 |
$1.74M |
199,764 |
| 2025-05-14 |
Ingenito Gary |
Chief Med. & Reg. Officer |
Vente Informative |
44,000 |
$23.63 |
$1.04M |
68,873 |
| 2025-05-13 |
Ingenito Gary |
Chief Med. & Reg. Officer |
Vente Informative |
200,000 |
$23.68 |
$4.74M |
68,873 |
| 2025-03-06 |
Ingenito Gary |
Chief Med. & Reg. Officer |
Vente Informative |
180,096 |
$21.67 |
$3.9M |
68,873 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
